Multiple myeloma (MM) is a B cell malignancy resulting in osteolytic lesions and fractures. In
the disease state, bone healing is limited owing to increased osteoclastic and decreased …

Multiple myelomas are a less frequent cancer site among both sexes. On a worldwide scale,
it is estimated that about 86 000 incident cases occur annually, accounting for about 0.8% of …

Multiple myeloma, a neoplasm of plasma cells, accounts for∼∼ 15% of
lymphatohematopoietic cancers (LHC) and 2% of all cancers in the US. Incidence rates …

Obesity is often linked to malignancies including multiple myeloma, and the underlying
mechanisms remain elusive. Here we showed that acetyl-CoA synthetase 2 (ACSS2) may …

Approximately 34 million US adults were obese in 1980. Obesity is associated with
increased risk of non-insulin-dependent diabetes mellitus (NIDDM), hypertension …

Multiple myeloma (MM) incidence is markedly higher in blacks compared with whites, which
may be related to a higher prevalence of monoclonal gammopathy of undetermined …

Excess body weight has been identified as a risk factor for various cancer types. Since the
publication of two meta-analyses indicating that body mass index (BMI) is positively …

The aggregate of epidemiological studies indicates a significantly elevated risk for cancer in
people with a high body mass index (BMI); a “dose–response” effect exists with increasing …

We studied the prevalence of monoclonal gammopathy of undetermined significance
(MGUS) in younger individuals, age 10–49 years, using samples from the National Health …

This review of the plasma-cell disorders begins with the definition of monoclonal
gammopathy of undetermined significance (MGUS). The prevalence of MGUS in white and …